leisure time -WSS

leisure time

author：explore 2025-10-01 00:47:53 - browse：97889

Photo illustration of the FDA US Food and Drug website. -- health policy coverage from STAT — Adobe

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday.

The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility. An investigation found that the delayed response was due in part to the agency’s organization. A nonprofit, nonpartisan advisory body reported in December it was not clear who is in charge of food oversight, and agency food safety staff are siloed among divisions that don’t communicate with each other.

Although the food center has been the focus of attention in the reorganization, it will affect a huge swath of the agency. The reorganization is expected to impact about 8,000 FDA employees, according to Michael Rogers, FDA associate commissioner for regulatory affairs. The Office of Regulatory Affairs, which will be called the Office of Inspections and Investigations under the proposed reorganization, will go from having about 5,100 full-time employees to 3,586 employees.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： 4th of July breaks record for highest global temperature ever measured

entertainment

hotspot

WSS

RaDonda Vaught case: a double standard for nurses, physicians

Community addresses injustice for Long Island mothers

Health officials lay out plans to cope with respiratory virus season

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

focus

leisure time

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Australia's humpback populations rebound raising hopes of marine scientists

Duchenne breakthrough therapy leaves behind pioneering families

Study: Spinal cord stimulation helps patients with paralysis walk again

BioMarin wins approval for gene therapy to treat hemophilia A

How the drug

Medical records are filled with copy

Listen: Biogen's messy board & Laronde's data problem

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Option Care buys Amedisys in $3.6 billion home care deal

leisure time

Kellogg’s is going to war over Mexico’s nutrition label rules

Intellia plays down concerns on accidental germline transmission

PBMs are inflating the cost of generic drugs. They must be reined in

CDC says it’s too soon to assess risk posed by Covid subvariant

Doctor appointment wait times are getting worse

How the drug

leisure time

entertainment

hotspot

hotspot